U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953739) titled 'A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953648) titled 'Remotely Monitored, Mobile Health-supported, High Intensity Interval Training Before Hematopo... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953830) titled 'Optimal Measurement of Spleen Stiffness Among Veterans With Metabolic Dysfunction-Associated ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954467) titled 'JS207 Combined With JS007 as First-line Treatment for Advanced Hepatocellular Carcinoma' on A... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953440) titled 'The Effect of Dexamethasone Submucosal Injection After Surgical Extraction of Lower Impacted ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954389) titled 'Hyperbaric Oxygen Therapy as a Neuroprotective Modality in Pediatric Acquired Brain Injury Wi... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952972) titled 'MorphECOS - Evaluation of the Influence of Fatigue and Sleep on the Performance of 2nd Cycle ... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06954701) titled 'Evaluation of a Personalizable Pessary for Pelvic Organ Prolapse' on April 17. Brief Summary... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06953167) titled 'Cognitive Health in Ageing Register: Investigational and Observational Trial Studies in Demen... Read More
U.S., May 2 -- ClinicalTrials.gov registry received information related to the study (NCT06952504) titled 'A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-34... Read More